Drawing for NUCURE

USPTO serial 88469915

NUCURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EISNACH, MICHAEL PATRICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUCURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maheen Baber

Maheen Baber MBIP LAW LLC2506 N CLARK STREET #437CHICAGO, IL 60614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Vitamin supplements; Herbal supplements; Nutritional supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 10, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 10, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 26, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2021EX2GSOU EXTENSION 2 GRANTED—
May 24, 2021EXT2SOU EXTENSION 2 FILED—
May 24, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 13, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 11, 2020EX1GSOU EXTENSION 1 GRANTED—
Nov 11, 2020EXT1SOU EXTENSION 1 FILED—
Nov 11, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 10, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Sep 10, 2019CNSLSUSPENSION LETTER WRITTEN—
Sep 4, 2019DOCKASSIGNED TO EXAMINER—
Jun 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance